SEC Form D · Amendment · filed September 23, 2020
Vergent Bioscience, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
John Santini · MINNEAPOLIS, MNExec · DirectorJeffrey Julkowski · MINNEAPOLIS, MNDirector · PromoterRyan D. Egeland · MINNEAPOLIS, MNDirectorSamuel D. Banks · MINNEAPOLIS, MNDirectorJeffrey D. Yurecko · MINNEAPOLIS, MNExecDouglas D. Kohrs · MINNEAPOLIS, MNDirectorRaymond D. Wong · MINNEAPOLIS, MNDirectorPeter W. Mooradian · Boston, MADirectorJohn C. Hansen · Westlake Village, CADirectorPhilip H. Lukowski · CHICAGO, ILExec · DirectorDavid R. Schwartz · CHICAGO, ILDirector · PromoterElizabeth C. Fujino · Westlake Village, CADirectorKyle Volluz · Dallas, TXExecPatrick Arippol · Sao Paulo, GuernseyDirectorCurtis Floyd · BAKERSFIELD, CADirectorBruce Beretta · BAKERSFIELD, CADirectorKevin S. Little · Boca Raton, FLDirector · PromoterNEF Assignment Corporation · Chicago, ILExec · DirectorJason Castle · BAKERSFIELD, CADirectorParamijt Dosanjh · BAKERSFIELD, CAExecAlison Forsyth · Somerville, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗